Target intelligence / Profile preview

Unfolded protein response (UPR) pathway components (UPR)

Target
UPR
Molecular classification
Enzyme, Transcription factor, Chaperone, Receptor
01

Overview

The Unfolded Protein Response (UPR) is a conserved adaptive signaling pathway triggered by the accumulation of misfolded proteins in the endoplasmic reticulum (ER), a condition termed ER stress (Hetz et al., 2020, Nature Reviews Molecular Cell Biology). It is regulated by three primary sensors: Inositol-requiring enzyme 1 alpha (IRE1α), Protein kinase RNA-like endoplasmic reticulum kinase (PERK), and Activating transcription factor 6 (ATF6) (Walter & Ron, 2011, Science). Under physiological conditions, these sensors are kept inactive by the chaperone BiP; upon stress, BiP dissociates, allowing the sensors to initiate downstream signaling to restore proteostasis (Wang & Kaufman, 2016, Nature). Initially, the UPR acts to reduce protein translation and increase the ER's folding capacity and degradation machinery. If ER stress is prolonged or severe, the UPR transitions from a cytoprotective role to a pro-apoptotic one, often involving the upregulation of CHOP (DDIT3). Dysregulation of the UPR is implicated in various pathologies, including cancer, where it supports tumor survival, and neurodegenerative diseases, where it contributes to neuronal loss. Pharmacological intervention targets these components using inhibitors like GSK2606414 (PERK) or KIRA6 (IRE1) to modulate cell fate in disease contexts (Grootjans et al., 2016, Gene Expression).

Other names
Endoplasmic reticulum stress pathwayER stress responseUPR signaling pathwayProteotoxic stress response
02

Mechanism of action

Modulation of ER stress sensors (PERK, IRE1, ATF6) to either restore proteostasis or trigger apoptosis in diseased cells.

03

Biological functions

Signal transductionApoptosisProtein foldingHomeostasisCell deathAutophagy
04

Disease associations

CancerNeurodegenerative diseaseDiabetes mellitusCardiovascular diseaseInflammationMetabolic disorder
05

Safety considerations

Pancreatic toxicitySystemic metabolic disruptionOff-target effects on high-secretory tissuesComplex pro-survival/pro-apoptotic balance
06

Interacting drugs

4-phenylbutyric acid

8 more in the full profile.

07

Biomarkers

Spliced XBP1 (sXBP1)CHOP (DDIT3) expressionPhosphorylated eIF2 alpha (p-eIF2α)BiP (GRP78) levelsATF4 protein levels

Beyond the preview

Go deeper on Unfolded protein response (UPR) pathway components (UPR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Unfolded protein response (UPR) pathway components (UPR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call